Form 4 for PG Procter & Gamble
Accepted 2024-11-25 00:00:00 ET · period of report 2024-11-21 · accession 0001127602-24-027949 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-25 | 2024-11-21 | PG | Purushothaman Balaji | CHRO | S - Sale+OE | $172.73 | -12.8K | 11.6K | -52% | -$2.21M |
| D | 2024-11-25 | 2024-11-21 | PG | Purushothaman Balaji | CHRO | M - OptEx | $91.07 | +12.8K | 24.4K | +110% | +$1.17M |
| D | 2024-11-25 | 2024-11-15 | PG | Purushothaman Balaji | CHRO | A - Grant | $0.00 | +4.80 | 13.78 | +53% | $0 |
| D | 2024-11-25 | 2024-11-21 | PG | Purushothaman Balaji | CHRO | M - OptEx | $0.00 | -12.8K | 12.8K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-21 | S | D | 12,800 | $172.73 | 11,595.43 | D | — | — | (F2) Weighted average price of the shares sold. The price range was $172.77 to $172.7201. Full information regarding the number of shares sold at each separate price available upon request. |
| 2 | Common | Common Stock | 2024-11-21 | M | A | 12,800 | $91.07 | 24,395.43 | D | — | — | (F1) Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. |
| 3 | Derivative | Restricted Stock Units | 2024-11-15 | A | A | 4.80 | $0.00 | 13.78 | D | — · — to — | 4.80 Common Stock | (F3) Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. (F4) These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. |
| 4 | Derivative | Stock Option (Right to Buy) | 2024-11-21 | M | D | 12,800 | $0.00 | 12,827 | D | $91.07 · 2020-02-28 to 2027-02-26 | 12,800 Common Stock |